Publications by authors named "Jane Rogers"

Claim this Profile
M
Management of Cancer During Pregnancy: ASCO Guideline.
Alison W Loren, Christina Lacchetti, Frédéric Amant, Elyce H Cardonick, Lisa A Carey, Jane E Rogers

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of KRAS codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumab.
Giulia Maddalena, Ymke van der Pol, Oscar E Villarreal, Oluwadara Coker, Hey Min Lee, Jane E Rogers

J Natl Cancer Inst· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memories of the Human Genome Project at the Sanger Centre.
Jane Rogers

Annu Rev Genomics Hum Genet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the pharmacokinetics of zolbetuximab in gastric adenocarcinoma.
Jane E Rogers, Michael Leung, Jaffer A Ajani

Expert Opin Drug Metab Toxicol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Therapeutics for Locally Advanced Upper Gastrointestinal Adenocarcinoma.
Jenny J Li, Jane E Rogers, Rebecca E Waters, Qiong Gan, Mariela Blum Murphy

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma.
Wendy M Covert, Jane E Rogers

Antibodies (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer.
Arjun S Peddireddy, Ryan Huey, Robert A Wolff, Kangyu Lin, Jocelyn Mitchell, Jane Rogers

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary management of advanced gastric and gastroesophageal adenocarcinomas.
Jane E Rogers, Jaffer A Ajani

Expert Rev Anticancer Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLOT vs CROSS in localized esophageal adenocarcinoma: what is the current best strategy?
Jane E Rogers, Michael Leung, Jaffer A Ajani

Expert Rev Clin Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.
Matheus Sewastjanow-Silva, Evan Kwiatkowski, Kohei Yamashita, Ahmed Abdelhakeem, Katsuhiro Yoshimura, Jane E Rogers

Int J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing landscapes and increasing relevance of immunotherapy in localized MSI-H gastric adenocarcinoma.
Jane E Rogers, Jaffer A Ajani

Expert Rev Clin Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted and combination immunotherapies using biologics for gastric cancer: the state-of-the-art.
Jane E Rogers, Qiong Gan, Rebecca E Waters, Ashley A Horak, Jaffer A Ajani

Expert Opin Biol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies.
Jane E Rogers, Jaffer A Ajani

Curr Opin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Clinical Pharmacist-Patient Telephone Follow-Up: A Focus on GI Medical Oncology Symptom Management.
Jane E Rogers, Jennifer Zadlo, Cheuk Hong Leung, Van Nguyen, Michael Leung

JCO Oncol Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel.
Kohei Yamashita, Matheus Sewastjanow-Silva, Katsuhiro Yoshimura, Jane E Rogers, Ernesto Rosa Vicentini

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study.
Matheus Sewastjanow-Silva, Lianchun Xiao, Graciela N Gonzalez, Xuemei Wang, Wayne Hofstetter, Jane E Rogers

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence to Date on the Therapeutic Potential of Zolbetuximab in Advanced Gastroesophageal Adenocarcinoma.
Jane E Rogers, Jaffer Ajani

Curr Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials.
Rishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, David S Hong, Timothy A Yap

J Gastrointest Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postpartum haemorrhage occurring in UK midwifery units: A national population-based case-control study to investigate incidence, risk factors and outcomes.
Madeline Elkington, Jennifer J Kurinczuk, Dharmintra Pasupathy, Rachel Plachcinski, Jane Rogers

PLoS One· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target.
Jane E Rogers, Kohei Yamashita, Matheus Sewastjanow-Silva, Allison Trail, Rebecca E Waters

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach.
Jane E Rogers, Amanda Sirisaengtaksin, Michael Leung, Van K Morris, Lianchun Xiao

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can You Establish the Cause of This Patient's Shortness of Breath?
Allison Trail, Jane Rogers, Jaffer Ajani

J Adv Pract Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Heatwaves on Cancer Care Delivery: Potential Mechanisms, Health Equity Concerns, and Adaptation Strategies.
Abbas M Hassan, Leticia Nogueira, Yu-Li Lin, Jane E Rogers, Amruta Nori-Sarma

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab combination therapy as first-line treatments for unresectable, advanced or metastatic esophageal squamous cell carcinoma.
Jane E Rogers, Kohei Yamashita, Matheus Sewastjanow-Silva, Ernesto Rosa Vicentini, Rebecca Waters

Expert Rev Anticancer Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Advances in the Treatment of Gastroesophageal Cancers.
Jenny J Li, Jane E Rogers, Kohei Yamashita, Rebecca E Waters, Mariela Blum Murphy

Biomolecules· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis